13 Patents
- US125841742026Treatment of Psoriasis with Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US125775622026Treatment of Glaucoma with Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US123702572025Materials and Methods of Treating Mhc-i-opathy Risk Haplotypes
Regeneron Pharmaceuticals, Inc.
0 cites - US122586272025Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US121863782025Methods of Treating Skin Cancer with Histidine Ammonia-lyase (HAL) Agonists
Regeneron Pharmaceuticals, Inc.
0 cites - US120496702024Proprotein Convertase Subtilisin/kexin Type 1 (PCSK1) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US119577042024Methods of Treating Metabolic Disorders and Cardiovascular Disease with Inhibin Subunit Beta E (INHBE) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US119396352024Treatment of Obesity in Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR)
Regeneron Pharmaceuticals, Inc.
0 cites - US118209822023Treatment of Ophthalmic Conditions with Son of Sevenless 2 (SOS2) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117594762023Methods of Treating Metabolic Disorders and Cardiovascular Disease with Inhibin Subunit Beta E (INHBE) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117521972023Macrophage Stimulating 1 Receptor (MST1R) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US116741772023Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites